Media
Company news
ChemDiv Expands Modeling & Simulation Services Platform, Signs Tenth Collaborator in 2026 - Mondego Bio
ChemDiv today announced the continued expansion of its Modeling & Simulation Services platform, highlighted by the signing of its tenth collaborator in 2026, Mondego Bio (Coimbra, Portugal), f...
Pop-Science
RNA Inhibitors: Small Molecules Targeting RNA | ChemDiv Libraries
Explore the new frontier of RNA Inhibitors and small molecules targeting RNA. Discover mechanisms, scientific validation, and purchase specialized screening libraries at ChemDiv.
Science & Nature Digest
Science & Nature Reviews, February 2022. Part II
Neurophysiology
Kelava, I., Chiaradia, I., Pellegrini, L. et al. Androgens increase excitatory neurogenic potential in human brain organoids. Nature 602, 112–116 (2022)
Sex-based brain dif...
Pharma News
NewAmsterdam Pharma Starts Phase 2b Trial of Obicetrapib in Alzheimer’s
NewAmsterdam Pharma has dosed its first patient in the Phase 2b SPINOZA trial to evaluate Obicetrapib in adults with preclinical Alzheimer’s disease.